Utility of Antibiotic Treatment in Acute Non-purulent Exacerbations of COPD: a Double Blinded, Randomized, Placebo-controlled Trial of Security and Efficacy.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AEPOC-ATB
- 05 Jul 2018 Status changed from active, no longer recruiting to completed.
- 11 Apr 2018 Planned End Date changed from 30 Jun 2018 to 30 Sep 2018.
- 11 Apr 2018 Planned primary completion date changed from 31 Mar 2018 to 30 Sep 2018.